Allergic rhinitis/conjunctivitis
Conditions
Interventions
Oraltek group (Apply Oraltek Sublingual Spray):None
Sponsors
Shulan (Bo'ao) Hospital
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: a. Patients must sign an informed consent form and possess the ability to adhere to study requirements; b. Age =5 years, both males and females are eligible; c. Diagnosed with allergic rhinitis/conjunctivitis with or without mild to moderate asthma, according to the criteria set by the ARIA guidelines and GINA 2023; d. Patients test positive for skin prick tests or specific IgE tests for one or more of the following allergens: house dust mites or dust mites, cat dander, dog dander, Alternaria alternata, horse dander, Artemisia vulgaris, Betula pendula/Alnus glutinosa/ Corylus avellana, 6 grasses (Holcus lanatus, Dactylis glomerata, Festuca pratensis, Poa pratensis, Lolium perenne, Phleum pratense) , Ambrosia artemisiifolia.
Exclusion criteria
Exclusion criteria: a. Patients with FEV1% < 80%, those with uncontrolled asthma, or severe asthma patients; b. Patients receiving treatment with ß-blockers or angiotensin-converting enzyme (ACE) inhibitors; c. Pregnant or breastfeeding women; d. Patients who are unable to understand or cooperate; e. Other patients deemed unsuitable for desensitization treatment by a physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rhinitis Combined Symptom and Medication Score;Asthma Combined Symptom and Medication Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS score;Common Adverse Reactions and Incidence;Patient dropout rate;Differences in adherence to desensitization therapy in patients with different allergens/ages and analysis of the reasons;Cost of treatment and its impact on adherence; | — |
Countries
China
Contacts
Public ContactYuefeng Sun
Hainan Shulan Bo'ao Hospital Co., Ltd.
Outcome results
None listed